Total Payments
$2,958
2024 Payments
$1,114
Companies
21
Transactions
126
Medicare Patients
633
Medicare Billing
$48,241
Payment Breakdown by Category
Food & Beverage$2,858 (96.6%)
Education$100.37 (3.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,858 | 124 | 96.6% |
| Education | $100.37 | 2 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $637.30 | 35 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $471.71 | 18 | $0 (2024) |
| Janssen Biotech, Inc. | $338.54 | 12 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $276.56 | 14 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $183.07 | 7 | $0 (2024) |
| Ironwood Pharmaceuticals, Inc | $179.68 | 7 | $0 (2023) |
| Phathom Pharmaceuticals, Inc. | $177.58 | 4 | $0 (2024) |
| Celgene Corporation | $166.80 | 7 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $104.72 | 4 | $0 (2024) |
| Gilead Sciences, Inc. | $60.81 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,114 | 42 | ABBVIE INC. ($221.11) |
| 2023 | $1,234 | 54 | ABBVIE INC. ($233.43) |
| 2022 | $579.66 | 28 | ABBVIE INC. ($170.41) |
| 2021 | $30.60 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($18.25) |
All Payment Transactions
126 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $1.86 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/07/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/20/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 09/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/04/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Immunology | ||||||
| 08/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/09/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: CRITICAL CARE | ||||||
| 07/08/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $39.31 | General |
| Category: THERAPY FOR CSID | ||||||
| 07/01/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Immunology | ||||||
| 06/28/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/27/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: IMMUNOLOGY | ||||||
| 06/21/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $84.00 | General |
| Category: Immunology | ||||||
| 06/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/20/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.64 | General |
| Category: Neuroscience | ||||||
| 06/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Gastroenterology | ||||||
| 06/03/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: Immunology | ||||||
| 06/03/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/28/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $3.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/20/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $46.33 | General |
| Category: Immunology | ||||||
| 05/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $30.09 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/13/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.96 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 150 | 205 | $31,570 | $11,438 |
| 2022 | 1 | 168 | 238 | $36,386 | $12,030 |
| 2021 | 2 | 122 | 188 | $27,100 | $10,032 |
| 2020 | 3 | 193 | 280 | $39,532 | $14,741 |
Total Patients
633
Total Services
911
Medicare Billing
$48,241
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 150 | 205 | $31,570 | $11,438 | 36.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 168 | 238 | $36,386 | $12,030 | 33.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 109 | 175 | $24,500 | $8,989 | 36.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 13 | $2,600 | $1,043 | 40.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 171 | 255 | $35,142 | $13,312 | 37.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 13 | $2,580 | $815.54 | 31.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 12 | $1,810 | $613.59 | 33.9% |
About Jillian Jaroszewski, PA-C
Jillian Jaroszewski, PA-C is a Medical healthcare provider based in Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/04/2014. The National Provider Identifier (NPI) number assigned to this provider is 1487051546.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jillian Jaroszewski, PA-C has received a total of $2,958 in payments from pharmaceutical and medical device companies, with $1,114 received in 2024. These payments were reported across 126 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,858).
As a Medicare-enrolled provider, Jaroszewski has provided services to 633 Medicare beneficiaries, totaling 911 services with total Medicare billing of $48,241. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Hartford, CT
- Active Since 12/04/2014
- Last Updated 02/22/2021
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1487051546
Products in Payments
- ENTYVIO (Biological) $354.66
- STELARA (Biological) $293.12
- XIFAXAN (Drug) $184.82
- OCALIVA (Drug) $183.07
- Linzess (Drug) $179.68
- VOQUEZNA (Drug) $177.58
- CREON (Drug) $174.46
- ZEPOSIA (Drug) $166.80
- DUPIXENT (Biological) $146.73
- RINVOQ (Biological) $121.54
- LINZESS (Drug) $120.93
- SKYRIZI (Biological) $119.70
- VIBERZI (Drug) $100.67
- TRULANCE (Drug) $91.74
- GATTEX (Drug) $84.97
- IBSRELA (Drug) $47.18
- Xolair (Biological) $46.33
- REMICADE (Biological) $45.42
- SUCRAID (Drug) $39.31
- ZENPEP (Drug) $36.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Hartford
Pamela Condon, Pa-C, PA-C
Medical — Payments: $15,397
Medical $15,397
Erin Frank, Pa, PA
Medical — Payments: $11,459
Medical $11,459
Kristen Rinaldi, Pa-C, PA-C
Medical — Payments: $4,948
Medical $4,948
Miss. Kelsey Burger, Pa-C, PA-C
Medical — Payments: $3,592
Medical $3,592
Danielle Gates, Pa, PA
Medical — Payments: $3,355
Medical $3,355
Edmond Beqiri, Mpa, MPA
Medical — Payments: $2,406
Medical $2,406